Unlike many other areas in health care, the practice of oncology presents unique challenges that make assessing and improving value especially complex. First, patients and professionals feel a well-justified sense of urgency to treat for cure, and if cure is not possible, to extend life and reduce the burden of disease. Second, treatments are often both life sparing and highly toxic. Third, distinctive payment structures for cancer medicines are intertwined with practice. Fourth, providers often face tremendous pressure to apply the newest technologies to patients who fail to respond to established treatments, even when the evidence supporting those technologies is incomplete or uncertain, and providers may be reluctant to stop toxic treatments and move to palliation, even at the end of life. Finally, the newest and most novel treatments in oncology are among the most costly in medicine.
This volume summarizes the results of a workshop that addressed these issues from multiple perspectives, including those of patients and patient advocates, providers, insurers, health care researchers, federal agencies, and industry. Its broad goal was to describe value in oncology in a complete and nuanced way, to better inform decisions regarding developing, evaluating, prescribing, and paying for cancer therapeutics.
Institute of Medicine. 2009. Assessing and Improving Value in Cancer Care: Workshop Summary. Washington, DC: The National Academies Press. https://doi.org/10.17226/12644.
|2 Opening Remarks: What Is Value in Cancer Care and Why Is It Important?||3-6|
|PART I: Challenges to Value in Cancer Care||7-8|
|3 Clinician–Patient Communication and Its Influence on Value||9-22|
|4 Generating Evidence About Effectiveness and Value||23-32|
|5 Value and the Oncology Market||33-54|
|6 Value in Oncology Practice: Oncologist and Health Insurer Perspectives||55-68|
|7 Ethical Issues and Value in Oncology||69-82|
|PART II:Solutions for Value in Cancer Care||83-84|
|8 Improving Value in Oncology Practice: Ways Forward||85-108|
|9 Toward a Shared Understanding of Value||109-116|
|Appendix A: Workshop Agenda||125-128|
|Appendix B: Speaker and Moderator Biographies||129-148|
The Chapter Skim search tool presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter. You may select key terms to highlight them within pages of each chapter.
The National Academies Press (NAP) has partnered with Copyright Clearance Center's Rightslink service to offer you a variety of options for reusing NAP content. Through Rightslink, you may request permission to reprint NAP content in another publication, course pack, secure website, or other media. Rightslink allows you to instantly obtain permission, pay related fees, and print a license directly from the NAP website. The complete terms and conditions of your reuse license can be found in the license agreement that will be made available to you during the online order process. To request permission through Rightslink you are required to create an account by filling out a simple online form. The following list describes license reuses offered by the National Academies Press (NAP) through Rightslink:
Click here to obtain permission for the above reuses. If you have questions or comments concerning the Rightslink service, please contact:
Rightslink Customer Care
Tel (toll free): 877/622-5543
To request permission to distribute a PDF, please contact our Customer Service Department at 800-624-6242 for pricing.
To request permission to translate a book published by the National Academies Press or its imprint, the Joseph Henry Press, pleaseclick here to view more information.